In the environmental monitoring business, meeting scheduling demands and performing critical-path compliance testing in pharmaceutical manufacturing – where downtime is measured in minutes – is a welcome challenge on the best of days, requiring effective coordination with numerous equipment vendors and outside testing labs. This challenge was amplified for us when the global health crisis created a spike in demand for specialized microbiological sampling equipment and lab analysis services. This has left vendors unable to reliably fulfill orders, increasing turnaround times downstream.
AMA has responded to this by making investments in equipment and personnel training, bringing in-house certain crucial testing and analysis functions previously performed by others. This saves costs, tightens test reporting timeframes, and ensures a rapid response to our clients’ always-evolving needs.